Fluorobenzene

Fluorobenzene

SCHEMBL27831735

CCOc1ccccc1C(=O)OC.Fc1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.59
SLC6A4 P31645 1/20 0.59
HCRTR1 O43613 2/20 0.55
L3MBTL1 Q9Y468 3/20 0.52
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 2/20 0.51
HTT P42858 2/20 0.51
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
GAA P10253 2/20 0.49
TDP1 Q9NUW8 3/20 0.49
KCNK3 O14649 1/20 0.49
KCNK9 Q9NPC2 1/20 0.49
RAB9A P51151 1/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30553984 0.91 HCRTR1 (0.65) SLC6A3HCRTR1L3MBTL1ALDH1A1MEN1
SCHEMBL1989129 0.91 HCRTR1 (0.65) SLC6A3HCRTR1L3MBTL1ALDH1A1MEN1
SCHEMBL21986975 0.84 HCRTR1 (0.58) SLC6A3HCRTR1L3MBTL1ALDH1A1MEN1
SCHEMBL4282830 0.82 HCRTR1 (0.62) SLC6A3HCRTR1L3MBTL1ALDH1A1MEN1
SCHEMBL5309541 0.82 KMT2A (0.64) SLC6A3SLC6A4L3MBTL1ALDH1A1MEN1
SCHEMBL25794823 0.81 TDP1 (0.62) SLC6A3SLC6A4HCRTR1ALDH1A1MEN1
SCHEMBL16616127 0.79 TDP1 (0.57) SLC6A3SLC6A4L3MBTL1ALDH1A1MEN1
SCHEMBL27413245 0.79 HSP90AA1 (0.57) SLC6A3SLC6A4L3MBTL1ALDH1A1MEN1
SCHEMBL28178040 0.79 HCRTR1 (0.58) HCRTR1L3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL7618555 0.79 SLC6A3 (0.56) SLC6A3HCRTR1L3MBTL1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106008322-B sulfonamide derivatives as BC L-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2018-09-04 CN disclosed
CN-106045893-A Apoptosis-inducing agents for treatment of cancer and immune and autoimmune diseases ABBVIE 公司 2016-10-26 CN disclosed
CN-106008322-A BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2016-10-12 CN disclosed
CN-102947285-B Sulfonamide derivatives as BCL-2-selective apoptosis inducers for the treatment of cancer and immune diseases ABBVIE (US) 2015-08-26 CN disclosed
CN-102307872-A BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBOTT LAB 2012-01-04 CN disclosed
CN-102282129-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 2011-12-14 CN disclosed